User profiles for Alexander Farahani

Alexander A. Farahani

Massachusetts General Hospital
Verified email at mgh.harvard.edu
Cited by 484

Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis

M Farahani, H Mulinder, A Farahani… - … journal of STD & …, 2017 - journals.sagepub.com
The advent of antiretroviral therapy has significantly improved AIDS-related morbidity and
mortality. Yet, among people living with HIV, deaths due to non-AIDS-defining illnesses have …

Lymph node metastases develop through a wider evolutionary bottleneck than distant metastases

…, ECE Wassenaar, WR Jeck, MS Taylor, AA Farahani… - Nature …, 2020 - nature.com
Genetic diversity among metastases is poorly understood but contains important information
about disease evolution at secondary sites. Here we investigate inter- and intra-lesion …

[HTML][HTML] Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)

YH Chu, D Dias-Santagata, AA Farahani, B Boyraz… - Modern Pathology, 2020 - Elsevier
Primary thyroid neoplasms with actionable NTRK rearrangements are rare, and their clinical
behavior, histologic characteristics, and molecular landscape are not well understood. We …

[HTML][HTML] Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization

YH Chu, LJ Wirth, AA Farahani, V Nosé, WC Faquin… - Modern Pathology, 2020 - Elsevier
The discovery of actionable kinase gene rearrangements has revolutionized the therapeutic
landscape of thyroid carcinomas. Unsolved challenges include histopathologic recognition …

[HTML][HTML] Diagnostic value of MAML2 rearrangements in mucoepidermoid carcinoma

JC Thierauf, AA Farahani, BI Indave, AZ Bard… - International journal of …, 2022 - mdpi.com
Mucoepidermoid carcinoma (MEC) is often seen in salivary glands and can harbor MAML2
translocations (MAML2+). The translocation status has diagnostic utility as an objective …

[HTML][HTML] Identification of fusions with potential clinical significance in melanoma

JMT Moran, LP Le, V Nardi, J Golas, AA Farahani… - Modern Pathology, 2022 - Elsevier
Though uncommon in melanoma, gene fusions may have therapeutic implications. Next
generation sequencing-based clinical assays, designed to detect relevant gene fusions, …

Implementation and clinical adoption of precision oncology workflows across a healthcare network

…, LM Spring, N Jessop, AA Farahani… - The …, 2022 - academic.oup.com
Background Precision oncology relies on molecular diagnostics, and the value-proposition
of modern healthcare networks promises a higher standard of care across partner sites. We …

Developmental deconvolution for classification of cancer origin

E Moiso, A Farahani, HD Marble, A Hendricks… - Cancer discovery, 2022 - AACR
Here we map the developmental trajectories of tumors. We deconvolute tumor transcriptomes
into signals for mammalian developmental programs and use this information to construct …

Integrated radiology, pathology, and pharmacy program to accelerate access to osimertinib

…, NZ Georgantas, FJ Fintelmann, A Farahani… - JCO Oncology …, 2023 - ascopubs.org
PURPOSE Targeted therapy yields superior outcomes relative to genotype-agnostic therapy
for patients with epidermal growth factor receptor (EGFR)-mutant lung cancer. Workflows …

Prognostic biomarkers for survival in mucosal melanoma

…, S Jobbagy, R Purohit, AA Farahani… - Pigment Cell & …, 2023 - Wiley Online Library
Mucosal melanoma (MM) is a rare subtype of melanoma with an aggressive clinical course.
In cutaneous melanoma (CM), the absence of pigmentation and presence of NRAS/KRAS …